623942-84-7 Usage
Uses
Used in Pharmaceutical Industry:
3-Bromo-2-(hydroxymethyl)-6-methoxypyridine is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of biologically active compounds. Its unique structure allows for the creation of new drugs with potential therapeutic effects.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Bromo-2-(hydroxymethyl)-6-methoxypyridine is utilized as an intermediate in the production of agrochemicals, contributing to the development of effective pesticides and other agricultural products that enhance crop protection and yield.
Used in Research and Development:
3-Bromo-2-(hydroxymethyl)-6-methoxypyridine is employed as a valuable compound in research and development settings due to its distinctive properties and reactivity. It aids scientists in exploring new chemical reactions and syntheses, potentially leading to innovative applications across various fields.
Overall, 3-Bromo-2-(hydroxymethyl)-6-methoxypyridine is an important chemical compound with a broad spectrum of potential uses across different industries, particularly in the development of new pharmaceuticals, agrochemicals, and organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 623942-84-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,2,3,9,4 and 2 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 623942-84:
(8*6)+(7*2)+(6*3)+(5*9)+(4*4)+(3*2)+(2*8)+(1*4)=167
167 % 10 = 7
So 623942-84-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H8BrNO2/c1-11-7-3-2-5(8)6(4-10)9-7/h2-3,10H,4H2,1H3
623942-84-7Relevant academic research and scientific papers
SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF
-
, (2019/10/15)
The present disclosure relates to novel compounds including formula (X) and pharmaceutical compositions thereof, and methods for inhibiting the activity of SHP2 phosphatase with the compounds and compositions of the disclosure. The present disclosure further relates to, but is not limited to, methods for treating disorders associated with SHP2 deregulation with the compounds and compositions of the disclosure.